Skip to content

Perspective Memory and Executive Functions in HIV+ Patients

Influence of Hot and Cold Cognition on Prospective Memory in HIV+ Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05752578
Acronym
(3514)
Enrollment
100
Registered
2023-03-02
Start date
2020-10-10
Completion date
2023-12-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

The primary goal of this observational study is to evaluate prospective memory in HIV+ patients compared to healthy subjects. The secondary goal is to examine the relationship between prospective memory and Hot Cognition (mechanical cognitive abilities) and Cold Cognition (cognitive abilities supported by emotion and social perception). The main questions it aims to answer are: * Do HIV+ patients have more impaired prospective memory than healthy subjects? * Is there a greater influence of Hot Cognition on prospective memory than Cold Cognition? Participants will undergo a battery of neuropsychological tests: Memory for Intentions Screening Test (MIST), Montreal Cognitive Assessment (MOCA), Interpersonal Reactivity Index and Modified Five Point Test.

Interventions

OTHERNeuropsychological testing

During the session the patient will be administered the Memory for Intentions Screening Test (MIST; Raskin et al., 2010) with the purpose of investigating prospective memory ability. Then during the same meeting the following tests will be offered to the patient: Montreal Cognitive Assessment (MOCA; Nasreddine. Translation Pirani et al 2006) investigating global cognitive performance; - Interpersonal Reactivity Index (IRI; Davis, 1980;1983- Italian version edited by Bonino et al, 1998) with the purpose of assessing cognitive and affective empathy (Hot cognition); Modified Five Point Test (Ruffi et al 1987) aimed at assessing figurative fluency (Cold cognition).

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

HIV+: * consent to participate in the study * diagnosis of HIV * Current antiretroviral therapy * age \>18 years * native Italian speaker

Exclusion criteria

HIV+: * age \<18 years * presence of major psychiatric disorders within the past 6 months * additional neurological conditions that may impair the performance of the tests (Alzheimer's disease, Outcomes of head-brain trauma, cerebrovascular episodes) * Alcohol and drug addiction within the past 6 months * Additional medical conditions that may impair neurocognitive profile and functional abilities (cerebrovascular damage, cardiac problems with functional impairment, severe liver disease) Inclusion Criteria HIV- : * consent to participate in the study * Absence of HIV infection (HIV-RNA negative) * age \>18 years * native speaker of Italian

Design outcomes

Primary

MeasureTime frameDescription
Prospective memory in HIV+ patients and healthy subjects1 yearProspective memory will be assessed through the following test: Memory for Intentions Screening Test (MIST).

Secondary

MeasureTime frameDescription
Influence of global cognitive performance on prospective memory1 yearMontreal Cognitive Assessment (MOCA) investigating global cognitive performance.
Influence of hot cognition on perspective memory1 yearInterpersonal Reactivity Index (IRI) with the purpose of assessing cognitive and affective empathy (Hot cognition).
Influence of cold cognition on perspective memory1 yearModified Five Point Test aimed at assessing figurative fluency (Cold cognition).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026